Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 127,166,254 shares of Common Stock outstanding as of April 9, 2026, as reported in the Form 10-K/A filed with the U.S. Securities and Exchange Commission on April 28, 2026.


SCHEDULE 13G



 
CRCM LP
 
Signature:Chun R. Ding
Name/Title:CRCM LP
Date:08/12/2026
 
CRCM LLC
 
Signature:Chun R. Ding
Name/Title:CRCM LLC
Date:08/12/2026
 
CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.
 
Signature:Chun R. Ding
Name/Title:CRCM INSTITUTIONAL MASTER FUND (BVI), LTD
Date:08/12/2026
 
CRCM B SPV, LP
 
Signature:Chun R. Ding
Name/Title:CRCM B SPV, LP
Date:08/12/2026
 
CRCM Fintech Fund, LP
 
Signature:Chun R. Ding
Name/Title:CRCM Fintech Fund, LP
Date:08/12/2026
 
CRCM SPECIAL SITUATIONS FUND LP
 
Signature:Chun R. Ding
Name/Title:CRCM SPECIAL SITUATIONS FUND LP
Date:08/12/2026
 
DING CHUN R
 
Signature:Chun R. Ding
Name/Title:DING CHUN R
Date:08/12/2026